|
Group
| |
Patients
|
low NLRs
|
intermediate NLRs
|
High NLRs
|
P-value
|
|---|
| | | |
(< 1.5: n = 99)
|
(1.5–3.5: n = 245)
|
(≥3.5: n = 38)
| |
|---|
|
Age (years)
|
< 75
|
289
|
78
|
182
|
29
|
0.675
|
|
≥75
|
93
|
21
|
63
|
9
| |
|
Sex
|
Male
|
232
|
57
|
154
|
21
|
0.509
|
|
Female
|
150
|
42
|
91
|
17
| |
|
BMI (Kg/m2)
| | |
22.3 ± 3.0
|
22.3 ± 3.2
|
21.0 ± 3.0
|
0.049
|
|
Smoking History
|
Yes
|
240
|
61
|
156
|
23
|
0.895
|
|
No
|
142
|
38
|
89
|
15
| |
|
PS
|
0–1
|
355
|
94
|
224
|
37
|
0.273
|
|
2
|
27
|
5
|
21
|
1
| |
|
Predicted post PFTsa
|
≥40
|
355
|
95
|
227
|
33
|
0.184
|
|
< 40
|
27
|
4
|
18
|
5
| |
|
Histology
|
Ad
|
264
|
79
|
166
|
19
|
0.003
|
|
Others
|
118
|
20
|
79
|
19
| |
|
Differentiation
|
Well
|
125
|
37
|
78
|
10
|
0.412
|
|
Mod/poor
|
257
|
62
|
167
|
28
| |
|
p-stage
|
IA
|
212
|
62
|
131
|
19
|
0.233
|
|
IB
|
170
|
37
|
114
|
19
| |
|
Child-Pugh Score
|
5
|
342
|
90
|
220
|
32
|
0.539
|
|
≥6
|
40
|
9
|
25
|
6
| |
|
eGFR (ml/min/1.73m2)
|
≥60
|
301
|
85
|
189
|
27
|
0.094
|
| |
< 60
|
81
|
14
|
56
|
11
| |
|
Albumin (g/dl)
| | |
4.1 ± 0.29
|
4.1 ± 0.35
|
4.1 ± 0.38
|
0.798
|
|
CRP (mg/dl)
| | |
0.14 ± 0.39
|
0.22 ± 0.43
|
0.87 ± 2.18
|
<0.001
|
- aPredicted postoperative values of FEV1.0 or DLCO less than 40% are defined as high-risk results of pulmonary function tests
- Ad adenocarcinoma, BMI body mass index, PFT pulmonary function test, PS performance status, p-stage pathological stage
